Fréquence critique de fusion : Questions médicales fréquentes
Nom anglais: Flicker Fusion
Descriptor UI:D005425
Tree Number:G14.370
Termes MeSH sélectionnés :
Prostatic Neoplasms
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fréquence critique de fusion : Questions médicales les plus fréquentes",
"headline": "Fréquence critique de fusion : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fréquence critique de fusion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-05",
"dateModified": "2025-02-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fréquence critique de fusion"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Phénomènes physiologiques oculaires",
"url": "https://questionsmedicales.fr/mesh/D009799",
"about": {
"@type": "MedicalCondition",
"name": "Phénomènes physiologiques oculaires",
"code": {
"@type": "MedicalCode",
"code": "D009799",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G14"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fréquence critique de fusion",
"alternateName": "Flicker Fusion",
"code": {
"@type": "MedicalCode",
"code": "D005425",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Natalia D Mankowska",
"url": "https://questionsmedicales.fr/author/Natalia%20D%20Mankowska",
"affiliation": {
"@type": "Organization",
"name": "Applied Cognitive Neuroscience Lab, Department of Human Physiology, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Anna B Marcinkowska",
"url": "https://questionsmedicales.fr/author/Anna%20B%20Marcinkowska",
"affiliation": {
"@type": "Organization",
"name": "Applied Cognitive Neuroscience Lab, Department of Human Physiology, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Pawel J Winklewski",
"url": "https://questionsmedicales.fr/author/Pawel%20J%20Winklewski",
"affiliation": {
"@type": "Organization",
"name": "2nd Department of Radiology, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Rita I Sharma",
"url": "https://questionsmedicales.fr/author/Rita%20I%20Sharma",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Physiology, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
},
{
"@type": "Person",
"name": "Jacek Kot",
"url": "https://questionsmedicales.fr/author/Jacek%20Kot",
"affiliation": {
"@type": "Organization",
"name": "National Centre for Hyperbaric Medicine, Institute of Maritime and Tropical Medicine in Gdynia, Medical University of Gdansk, 80-210 Gdansk, Poland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Prostate-Specific Membrane Antigen Uptake Heterogeneity in Mixed Ductal-Acinar Adenocarcinoma of the Prostate.",
"datePublished": "2023-06-08",
"url": "https://questionsmedicales.fr/article/37290403",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/RLU.0000000000004742"
}
},
{
"@type": "ScholarlyArticle",
"name": "ExoDx prostate test as a predictor of outcomes of high-grade prostate cancer - an interim analysis.",
"datePublished": "2023-05-16",
"url": "https://questionsmedicales.fr/article/37193776",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41391-023-00675-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Natural history of incidentally diagnosed prostate cancer after holmium laser enucleation of the prostate.",
"datePublished": "2023-02-02",
"url": "https://questionsmedicales.fr/article/36730281",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0278931"
}
},
{
"@type": "ScholarlyArticle",
"name": "The association between prostatitis and risk of prostate cancer: a National Health Insurance Database study.",
"datePublished": "2022-10-06",
"url": "https://questionsmedicales.fr/article/36201020",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00345-022-04165-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic role of plasma ORM2 in differentiating prostate cancer from benign prostatic hyperplasia.",
"datePublished": "2022-10-05",
"url": "https://questionsmedicales.fr/article/36198834",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00432-022-04380-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes physiologiques oculaires",
"item": "https://questionsmedicales.fr/mesh/D009799"
},
{
"@type": "ListItem",
"position": 3,
"name": "Fréquence critique de fusion",
"item": "https://questionsmedicales.fr/mesh/D005425"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fréquence critique de fusion - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fréquence critique de fusion",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fréquence critique de fusion",
"description": "Comment évaluer la fréquence critique de fusion ?\nQuels outils sont utilisés pour le diagnostic ?\nQuels sont les critères de diagnostic ?\nPeut-on diagnostiquer des troubles avec ce test ?\nQuel professionnel effectue ce diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=7#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fréquence critique de fusion",
"description": "Quels symptômes indiquent un problème de fusion ?\nLa sensibilité à la lumière est-elle un symptôme ?\nPeut-on ressentir des vertiges ?\nLes troubles de la vision sont-ils fréquents ?\nY a-t-il des signes de fatigue visuelle ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=7#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fréquence critique de fusion",
"description": "Comment prévenir les problèmes de fusion ?\nL'éclairage ambiant joue-t-il un rôle ?\nDes pauses régulières sont-elles nécessaires ?\nL'hydratation aide-t-elle à la prévention ?\nLes examens réguliers sont-ils importants ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=7#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fréquence critique de fusion",
"description": "Quels traitements sont disponibles pour ce problème ?\nLa thérapie comportementale aide-t-elle ?\nDes médicaments sont-ils prescrits ?\nLes exercices oculaires sont-ils efficaces ?\nQuand consulter un spécialiste ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=7#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fréquence critique de fusion",
"description": "Quelles complications peuvent survenir ?\nLes troubles neurologiques sont-ils possibles ?\nPeut-on développer une anxiété liée à la vision ?\nDes problèmes de coordination peuvent-ils survenir ?\nLes troubles de l'humeur sont-ils liés ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=7#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fréquence critique de fusion",
"description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il la fréquence critique de fusion ?\nLes troubles oculaires augmentent-ils le risque ?\nLe stress a-t-il un impact ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D005425?mesh_terms=Prostatic+Neoplasms&page=7#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la fréquence critique de fusion ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests visuels mesurant la perception de clignotement sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels outils sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des appareils comme les photomètres et les dispositifs de stimulation lumineuse sont employés."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "La mesure de la fréquence à laquelle le clignotement est perçu comme continu."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer des troubles avec ce test ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques ou visuels peuvent être identifiés."
}
},
{
"@type": "Question",
"name": "Quel professionnel effectue ce diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un ophtalmologiste ou un spécialiste de la vision réalise ces tests."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de fusion ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des maux de tête, fatigue oculaire ou difficulté à percevoir des mouvements peuvent survenir."
}
},
{
"@type": "Question",
"name": "La sensibilité à la lumière est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une sensibilité accrue à la lumière peut être liée à des problèmes de fusion."
}
},
{
"@type": "Question",
"name": "Peut-on ressentir des vertiges ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des vertiges peuvent survenir en raison de la perception altérée des lumières."
}
},
{
"@type": "Question",
"name": "Les troubles de la vision sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la vision floue peuvent être associés à des problèmes de fusion."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes de fatigue visuelle ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une fatigue visuelle peut se manifester par des difficultés à se concentrer sur des lumières clignotantes."
}
},
{
"@type": "Question",
"name": "Comment prévenir les problèmes de fusion ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter une exposition prolongée à des lumières clignotantes et faire des pauses régulières."
}
},
{
"@type": "Question",
"name": "L'éclairage ambiant joue-t-il un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un éclairage adéquat peut réduire la fatigue oculaire et les problèmes de fusion."
}
},
{
"@type": "Question",
"name": "Des pauses régulières sont-elles nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, faire des pauses fréquentes lors de l'utilisation d'écrans est recommandé."
}
},
{
"@type": "Question",
"name": "L'hydratation aide-t-elle à la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hydratation peut contribuer à la santé oculaire générale."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers chez un ophtalmologiste aident à détecter précocement les problèmes."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour ce problème ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des lunettes correctrices ou des thérapies visuelles peuvent être recommandées."
}
},
{
"@type": "Question",
"name": "La thérapie comportementale aide-t-elle ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie comportementale peut aider à gérer les symptômes associés."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils prescrits ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments peuvent être prescrits pour traiter des troubles sous-jacents."
}
},
{
"@type": "Question",
"name": "Les exercices oculaires sont-ils efficaces ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des exercices oculaires peuvent améliorer la perception visuelle et réduire la fatigue."
}
},
{
"@type": "Question",
"name": "Quand consulter un spécialiste ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de consulter si des symptômes persistent ou s'aggravent."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des migraines ou des troubles de la concentration peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent être exacerbés par des problèmes de fusion."
}
},
{
"@type": "Question",
"name": "Peut-on développer une anxiété liée à la vision ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété peut survenir en raison de la difficulté à traiter les stimuli visuels."
}
},
{
"@type": "Question",
"name": "Des problèmes de coordination peuvent-ils survenir ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes de coordination visuelle peuvent être une complication."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de l'humeur peuvent être associés à des problèmes de perception visuelle."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque principaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exposition prolongée à des écrans et des lumières vives augmente le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la fréquence critique de fusion ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la perception visuelle et la fréquence critique."
}
},
{
"@type": "Question",
"name": "Les troubles oculaires augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles comme la myopie ou l'astigmatisme peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les problèmes de perception visuelle et de fusion."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles visuels peuvent augmenter le risque."
}
}
]
}
]
}
Prostate-specific membrane antigen (PSMA) PET findings of mixed ductal-acinar adenocarcinoma of the prostate are rarely reported. We describe 18 F-PSMA-1007 PET/CT and delayed pelvic 18 F-PSMA-1007 PE...
Patient outcomes were assessed based on a pre-biopsy ExoDx Prostate (EPI) score at 2.5 years of the 5-year follow-up of ongoing prostate biopsy Decision Impact Trial of the ExoDx Prostate (IntelliScor...
Prospective, blinded, randomized, multisite clinical utility study was conducted from June 2017 to May 2018 (NCT03235687). Urine samples were collected from 1049 men (≥50 years old) with a PSA 2-10 ng...
At 2.5 years, 833 patients had follow-up data. In the EPI arm, biopsy rates remained lower for low-risk EPI scores than high-risk EPI scores (44.6% vs 79.0%, p < 0.001), whereas biopsy rates were iden...
This follow-up analysis captures subsequent biopsy outcomes and demonstrates that men receiving EPI low-risk scores (<15.6) significantly defer the time to first biopsy and remain at a very low pathol...
There is no consensus on the management plan for incidental prostate cancer (IPCa) after holmium laser enucleation of the prostate (HoLEP). This study aims to investigate the natural course of this di...
The medical records of a prospective cohort of patients with LUTS/BPH who underwent HoLEP between July 2008 and December 2020 at Seoul National University Hospital were retrospectively reviewed. Patie...
Among 2630 patients, 141 (5.4%) were diagnosed with IPCa after HoLEP. Pathologic T stage and magnetic resonance imaging results were highly associated with the physician's primary treatment decision-m...
The incidence of IPCa after HoLEP was 5.4%, and among these, approximately 20% proceeded with immediate definitive therapy and an additional 6% ultimately received definitive therapy within a median o...
Inflammation is thought to affect the development of prostate cancer (PCa). By retrospectively investigating the database of the National Health Insurance Service, this study attempted to perform a re...
Participants were aged ≥ 50 years. Patients diagnosed with prostatitis between 2010 and 2013 and matched controls were followed up until 2019. We selected controls with matched propensity scores for a...
A total of 746,176 patients from each group were analyzed. The incidence of PCa was significantly higher in the group with prostatitis (1.8% vs 0.6%, p < 0.001). The HR for PCa was significantly highe...
Prostatitis is associated with an increased incidence of PCa. Acute prostatitis is associated with higher risk of PCa than chronic prostatitis. Clinicians should inform patients with prostatitis that ...
Markers are needed to increase the diagnostic accuracy of prostate-specific antigen (PSA) in prostate cancer (PCa) screening. Mounting evidence has shown that plasma proteins can be hopeful biomarkers...
Tandem mass tag (TMT)-based proteomics and parallel reaction monitoring (PRM) analysis were used to screen the differential proteins and further validated in other independent studies (n = 539). Recei...
Three candidate proteins (DBP, LCAT and ORM2) were preliminarily screened. Subsequent validation studies revealed significant upregulation of ORM2 in PCa patients across other independent cohorts. ORM...
In summary, our study suggests that ORM2 could be treated as a complementary biomarker for PSA in distinguishing PCa from BPH....
The objective of our study is to compare the performance of systematic, targeted and combined biopsies in the same cohort for the detection of clinically significant prostate cancer (csCaP)....
We included patients coming for first series of prostate biopsies, from January 2016 to May 2020, with at least one PI-RADS lesion ≥3 on MRI. All patients underwent 12 systematic biopsies, combined wi...
We included 234 patients. Combined biopsies allowed a better detection rate of csCaP (59.4%) compared to systematic biopsies (55.6%, P=0.01) and targeted biopsies alone (44.4%, P<0.001). The same is t...
Combined biopsies provide the best detection rate for csCaP in our study....
Prostate cancer represents a significant public health challenge, with its management requiring precise diagnostic and prognostic tools. Prostate-specific membrane antigen (PSMA), a cell surface enzym...
To analyse multiparametric magnetic resonance imaging (mpMRI) characteristics and appearance of histopathologically proven non-cancerous intraprostatic findings focussing on quantity of prostatitis an...
In this retrospective analysis consecutive patients with mpMRI followed by MRI/TRUS-fusion biopsy comprising targeted (TB) and systematic biopsy (SB) cores without prostate cancer (PC) at histopatholo...
Seventy-two patients were analysed. The median baseline characteristics were PSA 5.4 ng/ml (4.0-7.9), PI-RADS classification 3 (2-4), prostate volume 43 ml (33-57), and PSA density 0.13 ng/ml...
Quantity of atrophy and prostatitis had different influence on MRI characteristics and increased within higher PI-RADS classification. Younger men had diffuse hypointense changes at T2w images, but le...
The impact of prostate radiotherapy on patient-reported health-related quality of life (HRQoL) significantly influences the outcomes of metastatic prostate cancer. We measured and compared HRQoL of me...
Between November 23, 2020, and November 21, 2022, we recruited 70 metastatic prostate cancer patients at the Department of Clinical Oncology at Suez Canal University Hospital. Patients were eligible i...
We observed clinically significant improvements in urinary and bowel functions between baseline, 3-month, 6-month, and 12-month intervals after receiving definitive prostate radiotherapy. Patients in ...
Cytoreductive prostate radiotherapy in metastatic prostate cancer patients significantly improved urinary functioning, preserved bowel functioning but was associated with worsening of sexual functioni...
This trial was registered on (27/04/2023) with pactr.samrc.ac.za, PACTR202305854600529, URL: https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=25510 ....
Basal cell carcinoma (BCC) of the prostate is a very rare histologic variant of prostate cancer, of difficult diagnosis and uncertain prognosis. In fact, despite the frequency of prostate cancer, only...
